Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Bavarian Nordic
  4. Bavarian Nordic — Marts 2023

Bavarian Nordic — Marts 2023

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
745 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • MatchM Offline
    MatchM Offline
    Match
    wrote on sidst redigeret af
    #670

    Den 29/4 2021 udsendte BN en pressemeddelelse vedr. prækliniske data fra ABNCoV2 vaccinen. De kom fra Rahoud University Medical Center i Holland. Og de var særdeles imponerende i forhold til mRNA vaccinerne. Den 18/3 2021 havde Michael Novod / Nordea været ude med den helt vilde forudsigelse, at såfremt BN's covid vaccine blev en succes, kunne kursen på BN's aktier nå 900 kr. Tja, det var dengang! Men der ligger selvfølgelig data klar, som givetvis også skal samkøres.

    1 Reply Last reply
    0
    • DarvinD Offline
      DarvinD Offline
      Darvin
      wrote on sidst redigeret af
      #671

      Langtidsaftaler kan sagtens komme først tror jeg. Den er på trapperne, efter udmeldinger. Med lidt færre resultater, grundet frafald af deltagere, men det var forventet. Fase 3 med foreløbige data (tror jeg) ca april og endelige data ca sept. hvis vi får de foreløbige data.

      1 Reply Last reply
      0
      • DarvinD Offline
        DarvinD Offline
        Darvin
        wrote on sidst redigeret af
        #672

        Langtids data skulle der stå

        1 Reply Last reply
        0
        • MatchM Offline
          MatchM Offline
          Match
          wrote on sidst redigeret af
          #673

          Den 23/8 2021 meddelte BN, at de igangsatte fase 2 forsøget med covid-vaccinen med 150 sunde mennesker, der havde erhvervet immunitet enten via covid smitte eller gennem vaccinatione med eksisterende vacciner. Her ville BN's vaccine skulle vise effekten af et boost af SARS-CoV-2 antibody i kroppen. Desuden fik 60 mennesker, de rikke tidligere havde været syge af covid 2 injektioner med vaccinen for at vurdere effekten af vaccinens evne til at booste immunforsvaret.

          1 Reply Last reply
          0
          • MatchM Offline
            MatchM Offline
            Match
            wrote on sidst redigeret af
            #674

            De forsøgspersoner må forlængst have været igennem tests for at klarlægge det aktuelle niveau at antistoffer mod covid-sygdom.

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #675

              Vi har fået langtidsdata, men venter på laaangtidsdata 😉

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #676

                Fase 3 første data forventes i april - slutdata i september iflg. CT.

                1 Reply Last reply
                0
                • W Offline
                  W Offline
                  WorkTrader
                  wrote on sidst redigeret af
                  #677

                  ...harmonerer fint med min åbning på tråden, men så læste jeg lige, at primary completion date, definerers som 'The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.'

                  1 Reply Last reply
                  0
                  • W Offline
                    W Offline
                    WorkTrader
                    wrote on sidst redigeret af
                    #678

                    så lidt forvirring der...

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      Kraken23
                      wrote on sidst redigeret af
                      #679

                      Kunne ønske der snart kom nogle ordre her 3 måneder inde i året

                      1 Reply Last reply
                      0
                      • W Offline
                        W Offline
                        WorkTrader
                        wrote on sidst redigeret af
                        #680

                        Biden administration warns of $35 billion shortfall for health emergency stockpile https://www.cbsnews.com/news/biden-administration-warns-of-35-billion-shortfall-for-health-emergency-stockpile/

                        1 Reply Last reply
                        0
                        • W Offline
                          W Offline
                          WorkTrader
                          wrote on sidst redigeret af
                          #681

                          "This year, the Biden administration hopes Congress can enshrine pandemic preparedness needs as mandatory funding, akin to military defense spending. Department officials have previously warned about challenges restocking supplies depleted for the mpox response, which used drugs and vaccines initially saved up for a potential smallpox attack."

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #682

                            Godmorgen 🙂

                            1 Reply Last reply
                            0
                            • F Offline
                              F Offline
                              Fandel
                              wrote on sidst redigeret af
                              #683

                              Godmorgen...

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Stroka
                                wrote on sidst redigeret af
                                #684

                                God morgen 🙂

                                1 Reply Last reply
                                0
                                • Cubinvest2021C Offline
                                  Cubinvest2021C Offline
                                  Cubinvest2021
                                  wrote on sidst redigeret af
                                  #685

                                  Interview med Expres2ions CEO i dag i biostock.se: “Along the way, ExpreS2ion has seen positive phase II data, and the next important milestone will be a top-line readout from the ongoing phase III study. This is expected sometime in mid-2023” https://www.biostock.se/en/2023/03/expres2ions-ceo-on-current-development-and-the-rights-issue/

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    Janolsen
                                    wrote on sidst redigeret af
                                    #686

                                    Hvornår kommer der nyt fra selskabet ? Er så træt af aktien konstant siver.

                                    1 Reply Last reply
                                    0
                                    • Cubinvest2021C Offline
                                      Cubinvest2021C Offline
                                      Cubinvest2021
                                      wrote on sidst redigeret af
                                      #687

                                      Jeg tror desværre, at vi må vente et par måneder før der kommer store nyheder angående Covid Fase III. De er ikke klar med data før juni tidligst. Medmindre at der kommer en stor ordre på Mpox eller partneraftale angående RSV...

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        Kirt
                                        wrote on sidst redigeret af
                                        #688

                                        Fra samme interview: – ABNCoV2 has a very competitive Covid-19 vaccine profile for several reasons. First of all, it has shown broad protection across variants of concern. So, while the virus continues to mutate, ABNCoV2 has continued to demonstrate protection. Secondly, it has shown a durability in protection – up to six months, which is very high in this field. Protection from the leading mRNA vaccines starts to wane at 3 – 4 months, requiring numerous booster injections. Let’s see if ...

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Kirt
                                          wrote on sidst redigeret af
                                          #689

                                          Nordic can also prove durability at 12 months very soon. Third, ABNCoV2 is based on a very stable protein construct that can be stored at refrigerator temperature and handled easily at room temperature – this is very promising for the supply-chain distribution of this vaccine in subtropical and tropical regions. Fourth, ABNCoV2 constitutes the only protein-based vaccine that does not need an adjuvant, which is indeed a very competitive advantage. Adjuvants are normal ingredients in most ....

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper